Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Variations in Kisspeptin Levels During Controlled Ovarian Hyperstimulation in Patients with Polycystic Ovary Syndrome and Their Relationship with Treatment Outcomes

  • By

  • Lu Han

  • Yiran Wang

  • Yueying Li

  • Xiaoyan Li

  • Jing Zhang

  • Yan Zhang

  • Mingfei Zhao

  • Haixia Chen

  • Huiying Zhang

  • Yingmei Wang

  • Fengxia Xue

  • Wenyan Tian

  • May 20, 2026

Share

  • 1

    Kisspeptin levels were significantly higher in PCOS patients during controlled ovarian hyperstimulation compared to controls.

  • 2

    Higher Kisspeptin levels correlated positively with ovarian reserve markers but negatively with top-quality embryo rates.

  • 3

    PCOS patients had more retrieved oocytes and embryos but lower cumulative pregnancy and live birth rates than controls.

  • 4

    Serum Kisspeptin levels on the day of oocyte pickup showed predictive value for pregnancy outcomes in PCOS patients.

  • 5

    The study highlights Kisspeptin's potential role in understanding reproductive dysfunction and optimizing treatment in PCOS.

Original Source(s)

Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes

  • by Lu Han, Yiran Wang, Yueying Li, Xiaoyan Li, Jing Zhang, Yan Zhang, Mingfei Zhao, Haixia Chen, Huiying Zhang, Yingmei Wang, Fengxia Xue, Wenyan Tian

  • May 20, 2026

Related Content

Ovarian intelligence: AI applications leveraging AMH and inhibin B

Retraction: Integrated multi-omics analysis reveals complement component 3 as a central driver of immune dysregulation in polycystic ovary syndrome

  • June 5, 2026

Immunological mechanisms of low-grade systemic inflammation and its role in endometrial dysfunction in women with polycystic ovary syndrome